Overweight and obesity, in particular, intra-abdominal adiposity, are associated with various cardiometabolic conditions including type 2 diabetes (T2D), dyslipidemia, hypertension, atherosclerotic cardiovascular disease, and heart failure [2, 3]
Because food remains in your stomach for longer, nutrients (like glucose) pass more slowly into your bloodstream
The conclusion is that tirzepatide is better for weight loss, though not necessarily easier to tolerate
Movement recommendations that account for your current ability, health conditions, injuries, energy, and daily life
Clear and colorless is the standard for injectable semaglutide
However, the diarrhea estimates were of low certainty due to high heterogeneity and wide confidence intervals, as indicated in Supplementary Table 7C